Miss Dikshyanta Rana

  • Research Associate (Health Economics & Health Technology Assessment)

telephone: +44(0)141 330 6613
email: Dikshyanta.Rana@glasgow.ac.uk

1 Lilybank Gardens, Glasgow, G12 8RZ

ORCID iDhttps://orcid.org/0000-0001-9133-3094

Biography

Dikshyanta joined HEHTA in 2018. She has experience in performing economic evaluations alongside clinical trials, decision-analytic modelling, analysing linked health data and evidence synthesis. To date, her projects have focused on diverse areas such as cardiovascular diseases, oncology, women’s health and learning disabilities.

Dikshyanta has an MSc in Health Economics from the University of York. Her MSc placement was at the Mental Health and Addiction Research Group (MHARG), University of York. She obtained her undergraduate degree in BA (Hons) Economics, with Minor subjects Psychology and Sociology from Christ University, India in 2016.

 

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020
Number of items: 12.

2022

Falkowski, A. et al. (2022) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (Early Online Publication)

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

2021

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

2020

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

This list was generated on Tue Aug 16 00:45:40 2022 BST.
Number of items: 12.

Articles

Falkowski, A. et al. (2022) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (Early Online Publication)

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Research Reports or Papers

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Conference or Workshop Item

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

This list was generated on Tue Aug 16 00:45:40 2022 BST.

Teaching

Dikshyanta is involved in a range of teaching activities within HEHTA, including supervision of MSc Health Technology Assessment (MSc HTA) and Master of Public Health (MPH) students. She contributes to the development and teaching of the HTA: Policy & Principles module on our MSc HTA programme and our Future Learn micro-credentials course Introduction to Health Economics & Health Technology Assessment. She moderates the discussion forum on our Future Learn MOOC. 

Dikshyanta tutors on our annual continuous professional development (CPD) courses Decision Analytic Modelling for Economic Evaluation and Evidence Synthesis for Health Technology Assessment. 

Dikshyanta also develops and delivers courses for external programmes such as the Better Health Programme (BHP) in the Philippines funded by the U.K. Foreign Commonwealth and Development Office Prosperity Fund in partnership with PricewaterhouseCoopers (PwC) and FHI 360.